Explore the groundbreaking field of miRNA-based therapy for BRCA mutations, its scientific foundations, current challenges, and future potential in cancer treatment.
Discover how CDS1 and CDS2 enzymes in lipid metabolism present a synthetic lethal target for treating mesenchymal cancers.